Supratentorial low-grade gliomas in older patients

Neurology

Volumn 73, Issue 24, 2009, Pages 2093-2098

  Kaloshi, G ^a   Psimaras, D ^a   Mokhtari, K ^b   Dehais, C ^a   Houillier, C ^a   Marie, Y ^c   Laigle Donadey, F ^a   Taillibert, S ^a   Guillevin, R ^a   Martin Duverneuil, N ^a   Sanson, M ^a,c,d   Hoang Xuan, K ^a,c,d   Delattre, J Y ^a,c,d  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; DATA BASE; FEMALE; GLIOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL;

EID: 73349083381     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181c6781e     Document Type: Article

References (14)

1. Claus EB, Horlacher A, Hsu L, et al. Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 2005;103:1227-1233.
2. Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 1998; 88:1-10.
3. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002;20:2076-2084.
4. Pouratian N, Mut M, Jagannathan J, et al. Low-grade gli-omas in older patients: a retrospective analysis of prognostic factors. J Neurooncol 2008;90:341-350.
5. Lowry JK, Snyder JJ, Lowry PW. Brain tumors in the elderly: recent trends in a Minnesota cohort study. Arch Neurol 1998;55:922-928.
6. Louis DN, Ohgaki H, Wiestler OD, et al. WHO classification of tumours of the central nervous system. Acta Neu-ropathol 2007;114:97-109.
7. Kaloshi G, Benouaich-Amiel A, Diakite F, et al. Temozo-lomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology 2007;68:1831-1836.
8. Hoang-Xuan K, Capelle L, Kujas M, et al. Temozolo-mide as initial treatment for adults with low-grade oli-godendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 2004;22: 3133-3138.
9. Wrensch M, Rice T, Miike R, et al. Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area. Neuro-Oncology 2006;8:12-26.
10. Legler JM, Ries LA, Smith MA, et al. Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999;91:1382-1390.
11. Scott JN, Brasher PM, Sevick RJ, et al. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 2002;59:947-949.
12. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002;20:2267-2276.
13. Karim ABMF, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade gli-oma in the adult: European Organization for Research and Treatment of Cancer study 22845 with the medical research council study bro4: an interim analysis. Int J Radiation Oncology Biol Phys 2002;52:316-324.
14. van den Bent MJ, Afra D, de Witte O, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 2005;366:985-990.